Q3 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript
I'd like to thank everybody for joining us this afternoon. As you have seen, Amphastar recently reported our financial results and I am pleased to announce that the upward momentum from last quarter's strong execution was sustainable and carried over into the third quarter.
With that said, we saw another great quarter of top line and bottom line growth, as we remain generally insulated from the typical challenges facing our sector in the pharmaceutical space. Again, this is another validating quarter, highlighting the importance of Amphastar's core strengths as our vision, strategy and vertical integrated platforms continue to deliver on our growing commercial proficiencies.
After my portion, I will turn the call over to our CFO and Executive Vice President of Finance, Bill Peters, who will provide an update on the company's financials. After Bill's remarks, we'll move on to the Q&A portion of the call where Tony Marrs, Senior Vice President of Regulatory Affairs and Clinical Operations, Bill and myself
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |